Concord Drugs has informed that the meeting of the Board of Directors of the Company is scheduled on 14/08/2018, to consider and approve the un-audited financial results for the quarter ended 30.06.2018; to fix the day, date, time and venue of the ensuing Annual General Meeting of the Company; and any other business with the permission of the Chair.
The above information is a part of company’s filings submitted to BSE.